Back to today’s briefing

Story perspectives

New Trial Rules Threaten COVID Vaccine Approvals, Healthcare Strain

5/13/2025

29 4

Summary

Story summary

Secretary Kennedy's new clinical trial requirements for the Novavax COVID-19 vaccine mark a significant shift from earlier streamlined approvals. This move could set a precedent for Pfizer and Moderna, jeopardizing the authorization of both COVID and flu vaccines. A reversal of CDC recommendations for children's vaccines could lead to tragic preventable deaths and strain our healthcare systems even further.

1 of 1

Story summary

Secretary Kennedy's new clinical trial requirements for the Novavax COVID-19 vaccine mark a significant shift from earlier streamlined approvals. This move could set a precedent for Pfizer and Moderna, jeopardizing the authorization of both COVID and flu vaccines. A reversal of CDC recommendations for children's vaccines could lead to tragic preventable deaths and strain our healthcare systems even further.